Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation
J Immunol (2018) 200 (7): 2247–2252.
Currently there are no citedby results. Try again later.
